Ron Boon

2.3k total citations
36 papers, 1.6k citations indexed

About

Ron Boon is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Ron Boon has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 12 papers in Pharmacology and 8 papers in Infectious Diseases. Recurrent topics in Ron Boon's work include Herpesvirus Infections and Treatments (18 papers), Cytomegalovirus and herpesvirus research (9 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Ron Boon is often cited by papers focused on Herpesvirus Infections and Treatments (18 papers), Cytomegalovirus and herpesvirus research (9 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). Ron Boon collaborates with scholars based in United States, United Kingdom and Australia. Ron Boon's co-authors include Robin Saltzman, R. Sutherland, Karen E. Griffin, B Slocombe, Alan R. White, Rick A. Barbarash, Stephen K. Tyring, Terry M. Jones, Spotswood L. Spruance and Anthony L. Cunningham and has published in prestigious journals such as Annals of Internal Medicine, Neurology and The Journal of Infectious Diseases.

In The Last Decade

Ron Boon

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ron Boon United States 19 1.0k 315 291 289 181 36 1.6k
Christina Y. Chan United States 18 873 0.9× 110 0.3× 156 0.5× 147 0.5× 49 0.3× 31 1.5k
Thomas Weinke Germany 19 900 0.9× 142 0.5× 416 1.4× 211 0.7× 90 0.5× 49 1.7k
Te‐Wen Chang United States 22 527 0.5× 129 0.4× 414 1.4× 91 0.3× 167 0.9× 67 1.2k
Kjell Alestig Sweden 24 1.1k 1.1× 339 1.1× 650 2.2× 26 0.1× 119 0.7× 82 2.2k
Richard J. Duma United States 26 1.1k 1.1× 225 0.7× 1.0k 3.5× 34 0.1× 390 2.2× 77 2.5k
Dieter W. Gump United States 23 417 0.4× 118 0.4× 169 0.6× 51 0.2× 165 0.9× 55 1.3k
Bruce L. Gilliam United States 21 540 0.5× 207 0.7× 744 2.6× 35 0.1× 101 0.6× 62 1.5k
Debbie Marriott Australia 18 494 0.5× 404 1.3× 572 2.0× 29 0.1× 90 0.5× 38 1.3k
Oren Zimhony Israel 20 507 0.5× 123 0.4× 965 3.3× 44 0.2× 364 2.0× 62 1.7k
R. F. Jacobs United States 22 1.2k 1.2× 324 1.0× 1.1k 3.7× 19 0.1× 357 2.0× 51 2.5k

Countries citing papers authored by Ron Boon

Since Specialization
Citations

This map shows the geographic impact of Ron Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Boon more than expected).

Fields of papers citing papers by Ron Boon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Boon. The network helps show where Ron Boon may publish in the future.

Co-authorship network of co-authors of Ron Boon

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Boon. A scholar is included among the top collaborators of Ron Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Boon. Ron Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veltri, Joseph C., et al.. (2021). A Randomized Exploratory Study to Investigate the Inflammatory Response During an Ultraviolet-Radiation-Induced Cold Sore Episode. Dermatology and Therapy. 11(3). 983–994. 1 indexed citations
2.
3.
Sarisky, Robert T., T. H. Bacon, Ron Boon, et al.. (2003). Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Archives of Virology. 148(9). 1757–1769. 35 indexed citations
4.
Veltri, Joseph C., et al.. (2002). Using community pharmacies to conduct an HSV‐1 prevalence study. Pharmacoepidemiology and Drug Safety. 11(5). 373–378.
5.
Raborn, G. Wayne, Alain Martel, M. Lassonde, et al.. (2002). Effective treatment of herpes simplex labialis with penciclovir cream. The Journal of the American Dental Association. 133(3). 303–309. 38 indexed citations
6.
Boon, Ron. (2002). Does iron have a place in the management of breath holding spells?. Archives of Disease in Childhood. 87(1). 77–a. 9 indexed citations
7.
Bacon, Teresa H., Ron Boon, Margaret Schultz, & Cheryl Hodges-Savola. (2002). Surveillance for Antiviral-Agent-Resistant Herpes Simplex Virus in the General Population with Recurrent Herpes Labialis. Antimicrobial Agents and Chemotherapy. 46(9). 3042–3044. 37 indexed citations
8.
Tyring, Stephen K., Robert Bélanger, W. R. Bezwoda, et al.. (2001). A Randomized, Double-Blind Trial of Famciclovir Versus Acyclovir for the Treatment of Localized Dermatomal Herpes Zoster in Immunocompromised Patients. Cancer Investigation. 19(1). 13–22. 53 indexed citations
9.
Trépo, C., et al.. (2000). Famciclovir in chronic hepatitis B: results of a dose-finding study. Journal of Hepatology. 32(6). 1011–1018. 21 indexed citations
10.
Boon, Ron, et al.. (2000). Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: A randomized, double-blind, placebo-controlled trial. Clinical Therapeutics. 22(1). 76–90. 37 indexed citations
11.
Dworkin, Robert H., et al.. (1998). Postherpetic Neuralgia: Impact of Famciclovir, Age, Rash Severity, and Acute Pain in Herpes Zoster Patients. The Journal of Infectious Diseases. 178(s1). S76–S80. 80 indexed citations
12.
Boon, Ron & David Griffin. (1995). Efficacy of famciclovir in the treatment of herpes zoster. Neurology. 45(12_suppl_8). S76–7. 17 indexed citations
13.
Dworkin, Robert H., Ron Boon, & David Griffin. (1995). Covariates in herpes zoster and interpretation of clinical trial data. Antiviral Research. 26(3). A344–A344. 5 indexed citations
14.
Saltzman, Robin, et al.. (1994). Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrobial Agents and Chemotherapy. 38(10). 2454–2457. 79 indexed citations
15.
Goodrick, M.J., Ron Boon, Rachel Bishop, J. A. Copplestone, & A. G. Prentice. (1993). Inaccurate haemoglobin estimation in Waldenström's macroglobulinaemia: unusual reaction with monomeric IgM paraprotein.. Journal of Clinical Pathology. 46(12). 1138–1139. 11 indexed citations
16.
17.
Boon, Ron, et al.. (1985). Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection. Journal of Antimicrobial Chemotherapy. 16(4). 519–526. 18 indexed citations
18.
Boon, Ron, et al.. (1985). Studies with Temocillin in the Hamster Model of Antibiotic-Associated Colitis1. Drugs. 29(Supplement 5). 57–63. 47 indexed citations
19.
BASKER, MICHAEL J., et al.. (1983). Properties of MM 13902 and other carbapenem antibiotics in vitro and in vivo.. The Journal of Antibiotics. 36(4). 416–422. 11 indexed citations
20.
Boon, Ron, et al.. (1982). Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections. Antimicrobial Agents and Chemotherapy. 22(3). 369–375. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina Y. Chan Breakdown of academic impact, for papers by Thomas Weinke Breakdown of academic impact, for papers by Te‐Wen Chang Breakdown of academic impact, for papers by Kjell Alestig Breakdown of academic impact, for papers by Richard J. Duma Breakdown of academic impact, for papers by Dieter W. Gump Breakdown of academic impact, for papers by Bruce L. Gilliam Breakdown of academic impact, for papers by Debbie Marriott Breakdown of academic impact, for papers by Oren Zimhony Breakdown of academic impact, for papers by R. F. Jacobs
Rankless by CCL
2026